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In this contribution, we report studies of the primary dynamics of
the drug–protein complexes of daunomycin with apo riboflavin-
binding protein. With femtosecond resolution, we observed the
ultrafast charge separation between daunomycin and aromatic
amino acid residues of the protein, tryptophan(s). Electron transfer
occurs from tryptophan(s) to daunomycin with two reaction times,
1 ps and 6 ps, depending on the local complex structure. The
formation of anionic daunomycin radical is crucial for triggering a
series of chemical reactions in redox cycling. One of the subsequent
reactions is the reduction of dioxygen to form active superoxide by
the reduced daunomycin. This catalytic process was found to occur
within 10 ps. In the absence of dioxygen, charge recombination
takes a much longer time, more than 100 ps. These results, along
with similar findings in DNA and nucleotides, elucidate that the
ultrafast generation of reduced daunomycin radicals by photoac-
tivation is a primary step for the observed photoenhancement of
drug cytotoxicity by several orders of magnitude. We also
studied the dependence of the dynamics on protein conforma-
tions at different ionic strengths and denaturant concentrations.
We observe a sharp transition from the tertiary structure to the
unfolding state at 2 M of denaturant concentration.
Daunomycin (DM, Fig. 1), an anthracycline antibiotic, is oneof the effective drugs used for cancer chemotherapy. It has
been shown that the cytotoxicity of DM is enhanced by several
orders of magnitude with irradiation of light, but the mechanism
by photoactivation is still unknown (1–3). In recent studies from
this group (X. Qu, C.W., H.-C. Becker, D.Z., and A.H.Z.,
unpublished work), we reported the striking observation of the
primary dynamics of DM when it intercalates into GC base pairs
of DNA or binds to nucleotides. Ultrafast electron-transfer (ET)
reactions between DM and the base G were found to occur on
the femtosecond to picosecond time scales (4). The reduced DM
radicals can catalyze superoxide formation from dioxygen (O2),
which then triggers redox cycling. Thus, molecular oxygen
becomes an integral part of the drug function.
Here, we report our studies of the dynamics of DM with a
protein. Many proteins have hydrophobic domains and can
interact with DM molecules. Aromatic or sulfur-containing
amino acid residues in proteins, such as Trp, Tyr, or cysteine, can
often function as reductants and donate electrons. One of the
flavoproteins, apo riboflavin-binding protein (apoRfBP) and a
riboflavin carrier in plasma, has several Trp residues in its
hydrophobic cleft (20 Å wide and 15 Å deep). This protein, a
single polypeptide chain of 219 amino acids, was chosen as a
prototype (Fig. 1) and the complex of DM–apoRfBP as a model
system.
As mentioned in the preceding paper (5), the x-ray crystal
structure reveals a compact p stack of riboflavin (vitamin B2)
sandwiched between Trp-156 and Tyr-75 at an equal interplanar
distance of 3.7 Å in the hydrophobic cleft of apoRfBP (6).
Ultrafast ET between riboflavin and Trp-156 is dominant and
occurs in ’100 fs, a very favorable process (5, 7). DM and
riboflavin have similar hydrophobic chromophores with a planar
three-ring structure (anthraquinone-type), and both have a
catalytic redox property. Thus, the drug DM inserts into the
hydrophobic cleft of the binding site, and the DM-apoRfBP
complex exhibits a similar ET reaction on photoinitiation.
Methodology. Femtosecond-resolved fluorescence up-conversion
and transient absorption techniques were used for all experi-
mental measurements. The experimental setup is described in
detail elsewhere (8). The pump pulse from an optical para-
metric amplifier (OPA) was attenuated to 0.1–0.4 mJ and fixed
at 480 nm, whereas for some experiments, the pump pulse was
tuned to 510 nm. The probe wavelength was set at 795 nm as
the gating pulse for up-conversion measurements. For tran-
sient absorption experiments, another OPA was used, and the
probe pulse was tuned from 315 to 700 nm. Most transients
were taken at the magic angle (54.7°) of the pump polarization,
relative to that of the probe pulse (transient absorption) or the
f luorescence (determined by the nonlinear crystal). The pump
polarization was also adjusted to be parallel or perpendicular,
and the resulting anisotropy was measured carefully: r(t) 5
(Ii 2 I’)y(Ii 1 2I’).
Sample Preparation. apoRfBP from chicken egg white (lyophilized
powder), L-tryptophan, antitumor drug of DM, and other sol-
vents (spectroscopy-grade) were purchased from Sigma. Ultra-
pure guanidine hydrochloride (GdnzHCl) was obtained from
Baker, and sodium chloride (NaCl) from Mallinckrodt. All
chemicals were used as supplied.
For most experiments, the lyophilized apoRfBP powder was
dissolved in 30 mM phosphate buffer at pH57 with a concen-
tration of 400 mM. DM was added into the solution with a
concentration of 50 mM, reaching a ratio of 8:1 for apoRfBP to
DM. We found that more than 98% of DM molecules bind to the
protein. The association constant was previously reported to be
2 3 106 M21 (9). The binding constant of DM to tryptophan in
buffer solution is much smaller, and we estimated it to be ’25
M21. For experiments involving the addition of the salt NaCl to
increase the ionic strength or the denaturing agent GdnzHCl to
unfold the protein, the mixed samples were allowed to equili-
brate for more than 3 h before use. For experiments of free drug
DM in buffer alone, a concentration of 10 mM DM was used to
minimize dimer formation (10). All samples were measured at
room temperature in a fused silicon cell with 1- to 3-mm path
length, and no photobleaching was observed.
The steady-state absorption and fluorescence emission spec-
tra of DM were studied in detail recently in this laboratory. After
the complexation of DM with apoRfBP, no apparent changes
were found in the absorption spectrum and fluorescence emis-
sion profile, except that the total f luorescence intensity of
drug–protein complexes (at 480 nm excitation) decreases by
several orders of magnitude.
Abbreviations: DM, daunomycin; Trp, tryptophan; apoRfBP, apo riboflavin-binding pro-
tein; ET, electron transfer; GdnzHCl, guanidine hydrochloride.
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Results and Discussion
Charge Separation and DM Reduction. The femtosecond-resolved
f luorescence transients of DM in the hydrophobic cleft of
apoRfBP are shown in Fig. 2A for a systematic series of
f luorescence wavelength detection. It is clear that all transients
show ultrafast dynamics on the femtosecond to picosecond
time scale with only a minor component (2–3%) in the
nanosecond range. The free DM molecule in water has been
well characterized (work in this group; refs. 11 and 12).
Basically, the first excited state has ’1 ns lifetime. At 480 nm
excitation, vibrational relaxation was found to occur in 200 fs
and up to 1 ps: ultrafast decay components at shorter wave-
length (530 nm) and the corresponding rising components at
longer wavelength (670 nm) were observed, in addition to the
nanosecond component. At 610 nm, we only observed the
relaxed-state emission with the nanosecond component, as
also shown in Fig. 2B. Little solvation dynamics was observed,
because no apparent changes of the dynamical transients as
well as the static emission peaks were found when DM
dissolves in solvents with different polarity. Thus, the observed
minor nanosecond component in the drug–protein complexes
results from the free, or nearly free, DM molecules in solution,
indicating that almost all DM molecules insert into the protein.
Fig. 1. Ribbon diagram of the x-ray structure of riboflavin-binding protein (6) and a view of the hydrophobic cleft. Also shown are the molecular structure of
DM and the stick presentation of Trp-156 amino acid residue (yellow) of the protein.
Fig. 2. (A) Femtosecond, normalized fluorescence up-conversion decays of the drug DM (50 mM) with apoRfBP (400 mM) for different-wavelength detection
at pH 5 7. (B) Comparison of the normalized fluorescence decays, detected at 610-nm emission, for DM in buffer water solution; with tryptophan (40 mM); and
with apoRfBP.
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As shown in Fig. 2 A, above 600 nm, all transients have the
same temporal behavior and decay in 1 ps (73%) and 6 ps (24%);
at 560 nm, the decay time constants are 0.8 ps (75%) and 5.8 ps
(22%); at 530 nm, they become 0.5 ps (83%) and 3.7 ps (15%).
The result at 610 nm gives accurate decay times for DM* in the
protein, because the contribution of vibrational relaxation is
negligible (Fig. 2B). At the blue side (530 nm and 560 nm), the
transients result from a superposition of decay dynamics and
vibrational relaxation. Thus, the decay of DM* in the protein has
two components (1 ps and 6 ps) with a ratio of 3:1.
The observed decay of DM* results from ET from Trp
residues in the protein to DM* for several reasons. Resonance
energy transfer is ruled out because of no spectral overlap
between DM* emission (.500 nm) and apoRfBP absorption
(,300 nm). Collision quenching by diffusion control occurs on
much longer time scale (.ns). Finally, a proton-transfer quench-
ing mechanism is also excluded because no intermolecular
proton transfer was observed in D2O, H2O, and methanol
solutions and at different pH.
The redox properties of DM and Trp give a favorable driving
force for the ET reaction: the potential for DMyDMz2 is ’20.4
V vs. NHE (ref. 13 and refs. therein) and for TrpyTrpz1, it is
’11.15 V vs. NHE (14). Knowing the 0–0 transition (S14S0)
energy of 2.3 eV, we obtained a net DG° of 20.75 eV. Ultrafast
ET between Trp-156 and riboflavin has been observed to occur
in ’100 fs (85%) and 700 fs (14%) at 480 nm excitation (5).
Here, we observed the same ET reaction with longer times (1 ps
and 6 ps). The big difference in ET rates is due to their binding
structures in the hydrophobic cleft, although the net DG° is only
20.35 eV for riboflavin in the protein. The chromophore part of
DM was shown to be mobile in the binding site by circular
dichroism (15). The perfect intercalation of DM in DNA (16)
also accelerates the ET reaction (290 fs and 1.7 ps) although the
net DG° (20.4 eV) is smaller than that of DM*-Trp complexes
in the protein.
We studied the decay dynamics of DM* in a tryptophan
solution (at the maximum Trp solubility of ’50 mM). To
minimize the formation of DM dimer, we used as low as 10 mM
concentration of DM. The observed transient is shown in Fig.
2B. Similar ET reaction time was observed as in the protein for
the small fraction that is not free in solution. The observed two
ET rates of DM in apoRfBP, as in DNA and nucleotides, are
attributed to two types of binding structures. Two ground-state
isomers of DM have been observed by NMR measurements
(17) and also proposed by theoretical calculations (18). Both
isomers are present in solution in a thermal equilibrium, and
f luorescence studies also confirm these two conformational
states.
To fully elucidate the ET mechanism, we performed tran-
sient absorption measurements to study the dynamics of the
charge-separated state and the ground-state recovery of DM.
Fig. 3 shows five transients probed in the range of 315–630 nm.
All transients have a positive absorption, except that at 480 nm
we observed a negative absorption. Specifically, at 630 and 510
nm, the two transients are nearly identical and have a rise
component of ’900 fs and a decay component of 4.8 ps. At 545
nm, the transient decays in 1 ps and 4.8 ps. But at 315 nm, the
transient is dominated by a 6-ps decay component. These
observations are very similar to those obtained for DM-
nucleotides and DM in DNA, and all transients ref lect the
excited-state DM*-Trp dynamics at these wavelengths: the
observed 1 ps and 4.8–6 ps decay components are consistent
with the results obtained by up-conversion f luorescence decay
measurements. Note that the probe wavelengths here are more
sensitive to the longer-time component (’6 ps). The initial rise
component (,1 ps) is attributed to vibrational relaxation,
consistent with the result observed for the free DM molecules
in bulk solvents.
To probe the recovery of DM or the ET product, we tuned the
pump wavelength to 510 nm and set the probe wavelength at 480
nm for the maximum ground-state absorption, detecting only the
480 nm transmission. At t 5 0, we observed a net negative signal,
which is the superposition of the ground-state depletion (neg-
ative) and the excited-state absorption (positive). After t 5 0, we
observed a dominant rise signal, reflecting either the formation
dynamics of the ET state or the ground-state DM recovery. To
distinguish these two processes, we have to understand the decay
dynamics of the ET state and the DM recovering process, which
are given below.
Role of Molecular Oxygen. Oxygen is present in solution (’1 mM
in air-exposed water), and its reduced form (O2
2) or singlet-
excited state (1O*2) plays an important role in biological
functions (19). All above transients were taken in aqueous
solution in presence of O2 (without degassing of O2). Fig. 4
shows the transient absorption signals taken without O2 and
under exposure to the air at 480-nm probe wavelength (lpu 5
510 nm). A clear difference was observed for the positive
absorption (DA.0). However, the excited-state DM*-Trp
dynamics measured by the transient absorption at 630 nm (Fig.
4B) does not show any noticeable change under these two
conditions. Thus, the presence of O2 in close proximity does
not inf luence the forward charge-separation rate but does
affect the ET-state decay dynamics, as observed in nucleotides
Fig. 3. Femtosecond transient absorption profiles of DM (50 mM) with
apoRfBP (400 mM) probed at different wavelengths, from 315 to 630 nm.
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and in DNA (X. Qu, C.W., H.-C. Becker, D.Z., and A.H.Z.,
unpublished work).
Upon purging with argon to remove O2, the transient initially
rises from a negative absorption to a positive one in 3.6 ps (66%)
and 7 ps (34%), and then decays in 135 ps (74%) and ’950 ps
(26%). Note that the small net positive signal is sensitive to the
absorption difference of the ET state and the ground state, and
the charge-recombination rate. The observed rise times are
consistent with the excited-state DM*-Trp decay dynamics
(’1–6 ps), reflecting the formation of the DMz2-Trpz1 state.
The long decay component (.100 ps) represents the charge
recombination without involvement of O2, that is, the electron
recombination to from the final ground state of DM.
When the sample was exposed to air, the amplitude of the
negative absorption shows nearly no change but the positive
signal decreases by a factor of ’2. The rise components appar-
ently become longer but the decay components keep the same.
In buffer solution, there exists equilibrium between O2 and the
DM–Trp complexes in the hydrophobic cleft. Thus, the observed
positive absorption in air is still from the DM–Trp complexes
without the influence of O2. The total signal was best fitted by
two components under the same forward ET rates and the same
absorptions for the ET state and the ground-state DM, as
shown in the Fig. 4A Inset. One component (47%) is from the
DMz2-Trpz1 complexes without O2, and the other one (53%) is
from the DMz2-Trpz1 (O2) complexes with ’10 ps recovering
time for the ground-state DM.
We note that if the reaction of DMz2-Trpz1 with O2 takes
longer than 10 ps and less than 100 ps, the positive signal,
compared with that in the absence of O2, does become smaller,
but the decay times also become shorter, inconsistent with our
observation. Therefore, our observed decrease of the positive
absorption and invariance of the decay times support the pres-
ence of two components under aerated conditions and the
reduction of O2 by DMz2occurs in less than 10 ps to form the
active superoxide O2
2 and ground-state DM. The overall mech-
anism is illustrated in Fig. 5, and the scheme resembles that for
the drugyDNA, nucleotide systems.
The observed fast ET reaction of DMz2 with O2 is energeti-
cally favorable based on the net DG° [20.24 eV; DMy
DMz2’20.4 V vs. NHE and O2yO2
2’20.16 V vs. NHE (20)].
Compared with the reaction time of DMz2-O2 (,3 ps) in
aqueous solution of nucleotides, the observed longer reaction
time with O2 in the protein is probably due to the change of redox
potentials in hydrophobic environments. It should be pointed out
that O2 binding to the DM–Trp complex takes place already in
the ground state in the protein cleft, because the diffusion-
controlled reaction will occur on a much longer time scale
(’microseconds) at our concentrations.
The identification of O2
2 formation is important because O2
2
is a very active species in the biological reactions. It has been
known that redox cycling, an important role for drug cytotox-
icity, begins with the formation of the DMz2 anionic radical and
then the radical reacts with O2 to form superoxide O2
2 (ref. 13
and refs. therein, refs. 21 and 22). Thus, the photoinitiated
ET-state formation by femtosecond pulses leads to the forma-
tion of drug radicals (anionic) on an ultrafast time scale, and
these radicals could trigger a series of chemical reactions in redox
cycling with much higher efficiency and enhance cell killing by
the anticancer drug. With DNA and nucleotides, this concept of
short-range oxygen involvement is clear, and its presence in
proteins elucidates the role of hydrophobicity in both systems.
Conformation vs. ET Rate. Because the ET rate between DM* and
Trp in the protein is sensitive to their relative positions, we
studied the ET reaction by changing protein conformations by
adding two different salts into the protein solution. Fig. 6 shows
our results. By increasing the ionic strength to 4 M NaCl, the
transient (Fig. 6A) changes and gives four decay times: 1.5 ps
(56%), 9.2 ps (28%), 89 ps (7%), and 1.1 ns (9%). These
observations are interesting in that they contrast those obtained
in RfBP, where the transient showed no significant change under
the same condition (5). The long components (89 ps and 1.1 ns)
account for up to 16% of the total signal, and it is only 2–3%
without NaCl. These results reveal that the protein at 4 M NaCl
pushes DM molecules out of the tight hydrophobic pocket.
Fig. 4. (A) Femtosecond transient absorption profiles of DM-apoRfBP complexes in the absence of dioxygen and under exposure to the air. The transient under
the aerated condition is best represented by two components with (53%) and without dioxygen (47%); see Inset. (B) Comparison of transient absorption profiles
without dioxygen and under the aerated condition at different probe wavelengths of 480 and 630 nm (see Inset). Note that the transients under two conditions
at 630-nm probe are identical, showing that excited-state dynamics of DM*-apoRfBP are the same; see text for details.
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To further characterize these ‘‘free’’ DM molecules, we mea-
sured the time-resolved anisotropy, as shown in Fig. 6A Inset.
The anisotropy [r(t)] decays with a time constant of 310 ps and
then remains constant at 0.061. The anisotropy decay time of
free DM molecules in buffer water without protein is 200 ps.
Therefore, the DM molecules, which are pushed out of the direct
ET-reaction center by adding 4 M NaCl, are not totally free and
still in proximity to the protein, leading to a longer anisotropy
decay time and a hindered rotation motion.
The transients obtained after adding the ionic denaturant
GdnzHCl are shown in Fig. 6B with a series of concentrations.
Clearly, when the concentration reaches 2 M, all of the DM
molecules behave like free molecules (nanosecond decay), and
no ultrafast ET reaction was observed. As mentioned in the
preceding paper (5), it has been reported that the unfolding of
the native RfBP protein occurs in two phases from 0 to 6 M
GdnzHCl, as measured by circular dichroism and f luorescence
spectra (23). Between 0–2 M GdnzHCl, the loss of its tertiary
structure and binding ability to ribof lavin occurs, but the
protein still remains in its secondary structure. At the high
concentration of 4–6 M GdnzHCl, the loss of the secondary
structure takes place and between 2–4 M GdnzHCl, and there
probably exists an intermediate conformation, a molten-
globule state. The absence of the ET reaction in our transients
at 2 M GdnzHCl undoubtedly indicates the collapsing of the
hydrophobic cleft, consistent with the loss of the tertiary
structure. The complete collapse of the binding site occurs at
3 M GdnzHCl (5).
Conclusion
The reported studies with femtosecond resolution of the drug–
protein complex, DM with apoRfBP, elucidate the different time
scales involved in charge separation, recombination, and the
involvement of dioxygen. The process involving the formation of
DM anionic radicals is critical to the drug function. Both the
photoactivated and thermal reactions are likely to have similar
Fig. 5. A reaction scheme for the ET from tryptophan(s) in the hydrophobic cleft of the protein to the drug DM. The solid arrows represent the observed ET
processes by photoactivation. The lighter dashed line represents the thermal reaction pathway involving a barrier crossing, a much slower process. The dashed
arrow indicates the final charge recombination. (Inset) The elementary steps involved in the photoinitiated ET processes.
Fig. 6. (A) Femtosecond fluorescence up-conversion decays of DM (50 mM) with apoRfBP (400 mM), detected at 610 nm, without and with the addition of the
ionic salt NaCl. The Inset gives the time-resolved anisotropy [r(t)] of DM in the protein with a concentration of 4 M NaCl. Note the difference in the time scale
between the fluorescence and anisotropy decay. (B) Fluorescence decays (610 nm) of DM (50 mm) bound to the apoRfBP (400 mM) with a series of concentrations
of GdnzHCl, from 0 M to 2 M.
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transition states (24, 25), with the latter being much slower in the
rate due to the involvement of a barrier crossing (see Fig. 5). The
resulting anionic DM radical can trigger a series of chemical
reactions in redox cycling under physiological conditions. One of
the subsequent reactions is the reduction of molecular oxygen in
close proximity, not diffusive, as shown here and elsewhere (X.
Qu, C.W., H.-C. Becker, D.Z., and A.H.Z., unpublished work).
As with DNA, this primary step is important for the observed
photoenhancement of drug cytotoxicity by several orders of
magnitude. Another major result of this study is the use of ET
rates as a sensitive probe of the local binding structure of the
protein, which is revealed by the unfolding processes observed in
our transients.
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